Investment
Features
FeesSafety
Academy
More
Pluang+

TNR Gold probes alleged secret plot to seize board control via undisclosed share acquisitions.

Market News
17 Sep 2026
Proactive Investors
View Source
Bearish
TNR Gold probes alleged secret plot to seize board control via undisclosed share acquisitions.

TNR Gold Corp is investigating a potential conspiracy involving Eucalyptus Resources Opportunities Fund 1, LP and others to secretly acquire and vote shares to gain control of its board. The scheme, reportedly led by Jon Christian "JC" Evensen, may violate securities laws and extends beyond what has been publicly disclosed. Despite demands for transparency, no corrective disclosures have been made ahead of the company's shareholder meeting on September 22, 2026. TNR Gold is concerned shareholders may lack critical information for voting and is considering actions to protect shareholder interests and voting integrity. The investigation is ongoing, with further updates expected.

TNR Gold's investigation into an alleged share acquisition conspiracy provides context for readers following the company. For readers following Basic Materials-sector stocks on Pluang, here is the market snapshot as of Sep 17, 2026 23:41 WIB: Of 31 priced US stocks, 26 rose and 5 fell today. Notable movers include SLI (Standard Lithium Ltd) at USD 2.17 with a 5.61% increase and a typical hold time of 21 days, ALB (Albemarle Corp.) at USD 115.39 with a 5.41% rise and Pluang order activity showing 73% Sell / 27% Buy, and LAC (Lithium Americas Corp) at USD 2.92 with a 5.04% gain and 100% Buy order activity, typical hold time 24 days.

More News

KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...

Company Fundamentals
Bearish
39 minutes ago
$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...

Market News
Bullish
2 hours ago
W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...

Analyst Insights
Bullish
2 hours ago
Micron invests $10B in new research labs, backed by strong financial health and strategic leadership.

Micron invests $10B in new research labs, backed by strong financial health and strategic leadership.

Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...

Market News
Bullish
2 hours ago
Impact Biomedical executes 1-for-12.62 reverse stock split ahead of Zoar Ltd. merger

Impact Biomedical executes 1-for-12.62 reverse stock split ahead of Zoar Ltd. merger

Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App